Cargando…

Relationships Between Adherence to Guideline Recommendations for Pharmacological Therapy Among Clinicians and Psychotic Symptoms in Patients With Schizophrenia

BACKGROUND: Clinician adherence to guideline recommendations in the pharmacological therapy of schizophrenia is important for favorable patient outcomes. To evaluate whether prescriptions followed the guidelines for pharmacological therapy of schizophrenia, we recently developed a summary indicator...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kodaka, Fumitoshi, Ohi, Kazutaka, Yasuda, Yuka, Fujimoto, Michiko, Yamamori, Hidenaga, Hasegawa, Naomi, Ito, Satsuki, Fukumoto, Kentaro, Matsumoto, Junya, Miura, Kenichiro, Yasui-Furukori, Norio, Hashimoto, Ryota
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2023
Materias:	Regular Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10464927/ https://www.ncbi.nlm.nih.gov/pubmed/37381793 http://dx.doi.org/10.1093/ijnp/pyad037

Ejemplares similares

Better adherence to guidelines among psychiatrists providing pharmacological therapy is associated with longer work hours in patients with schizophrenia
por: Ito, Satsuki, et al.
Publicado: (2023)

Relationship between autistic traits and social functioning in healthy individuals
por: Demizu, Yuria, et al.
Publicado: (2022)

Longitudinal characteristics of insight and clinical factors in patients with schizophrenia
por: Sakai, Yoshie, et al.
Publicado: (2023)

How to diagnose the 22q11.2 deletion syndrome in patients with schizophrenia: a case report
por: Ohi, Kazutaka, et al.
Publicado: (2013)

A Brief Assessment of Intelligence Decline in Schizophrenia As Represented by the Difference between Current and Premorbid Intellectual Quotient
por: Ohi, Kazutaka, et al.
Publicado: (2017)

A 1.5-Year Longitudinal Study of Social Activity in Patients With Schizophrenia
por: Ohi, Kazutaka, et al.
Publicado: (2019)

Genome-wide Association Analysis of Eye Movement Dysfunction in Schizophrenia
por: Kikuchi, Masataka, et al.
Publicado: (2018)

Sensory cognitive abnormalities of pain in autism spectrum disorder: a case–control study
por: Yasuda, Yuka, et al.
Publicado: (2016)

Genetic Overlap between General Cognitive Function and Schizophrenia: A Review of Cognitive GWASs
por: Ohi, Kazutaka, et al.
Publicado: (2018)

Comparison of eye movements in schizophrenia and autism spectrum disorder
por: Shiino, Tomoko, et al.
Publicado: (2019)

S239. PREDICTIVE ACCURACY FOR WORK OUTCOME IN PATIENTS WITH SCHIZOPHRENIA
por: Sumiyoshi, Chika, et al.
Publicado: (2018)

Predicting employment status and subjective quality of life in patients with schizophrenia
por: Fujino, Haruo, et al.
Publicado: (2015)

A Naturally Occurring Null Variant of the NMDA Type Glutamate Receptor NR3B Subunit Is a Risk Factor of Schizophrenia
por: Matsuno, Hitomi, et al.
Publicado: (2015)

Brain morphological and functional features in cognitive subgroups of schizophrenia
por: Yasuda, Yuka, et al.
Publicado: (2019)

The impact of the genome-wide supported variant in the cyclin M2 gene on gray matter morphology in schizophrenia
por: Ohi, Kazutaka, et al.
Publicado: (2013)

Gene expression analysis in lymphoblasts derived from patients with autism spectrum disorder
por: Yasuda, Yuka, et al.
Publicado: (2011)

Subcortical association with memory performance in schizophrenia: a structural magnetic resonance imaging study
por: Koshiyama, Daisuke, et al.
Publicado: (2018)

Role of subcortical structures on cognitive and social function in schizophrenia
por: Koshiyama, Daisuke, et al.
Publicado: (2018)

Effects of age and sex on eye movement characteristics
por: Takahashi, Junichi, et al.
Publicado: (2021)

Impaired inhibition of return during free-viewing behaviour in patients with schizophrenia
por: Okada, Ken-ichi, et al.
Publicado: (2021)

Semantic Memory Organization in Japanese Patients With Schizophrenia Examined With Category Fluency
por: Sumiyoshi, Chika, et al.
Publicado: (2018)

Methylation Analysis in Monozygotic Twins With Treatment-Resistant Schizophrenia and Discordant Responses to Clozapine
por: Kikuchi, Masataka, et al.
Publicado: (2021)

Impact of the Genome Wide Supported NRGN Gene on Anterior Cingulate Morphology in Schizophrenia
por: Ohi, Kazutaka, et al.
Publicado: (2012)

Dietary Intake of Sulforaphane-Rich Broccoli Sprout Extracts during Juvenile and Adolescence Can Prevent Phencyclidine-Induced Cognitive Deficits at Adulthood
por: Shirai, Yumi, et al.
Publicado: (2015)

Eye Movement Abnormalities in Major Depressive Disorder
por: Takahashi, Junichi, et al.
Publicado: (2021)

The p250GAP Gene Is Associated with Risk for Schizophrenia and Schizotypal Personality Traits
por: Ohi, Kazutaka, et al.
Publicado: (2012)

Variants of the RELA Gene are Associated with Schizophrenia and their Startle Responses
por: Hashimoto, Ryota, et al.
Publicado: (2011)

Duplication of the NPHP1 gene in patients with autism spectrum disorder and normal intellectual ability: a case series
por: Yasuda, Yuka, et al.
Publicado: (2014)

Glutamate Networks Implicate Cognitive Impairments in Schizophrenia: Genome-Wide Association Studies of 52 Cognitive Phenotypes
por: Ohi, Kazutaka, et al.
Publicado: (2015)

Frequency of mental disorders among chronic pain patients with or without fibromyalgia in Japan
por: Miki, Kenji, et al.
Publicado: (2018)

Transdiagnostic comparisons of intellectual abilities and work outcome in patients with mental disorders: multicentre study
por: Sumiyoshi, Chika, et al.
Publicado: (2022)

Altered sulcogyral patterns of orbitofrontal cortex in a large cohort of patients with schizophrenia
por: Isomura, Shuichi, et al.
Publicado: (2017)

Development of an individual fitness score (IFS) based on the depression treatment guidelines of in the Japanese Society of Mood Disorders
por: Fukumoto, Kentaro, et al.
Publicado: (2022)

Whole-exome sequencing and neurite outgrowth analysis in autism spectrum disorder
por: Hashimoto, Ryota, et al.
Publicado: (2016)

Development of individual fitness score for conformity of prescriptions to the “Guidelines For Pharmacological Therapy of Schizophrenia”
por: Inada, Ken, et al.
Publicado: (2022)

T8. ANTIPSYCHOTIC TREATMENT AND EYE MOVEMENT ABNORMALITIES IN SCHIZOPHRENIA
por: Takahashi, Junichi, et al.
Publicado: (2020)

Impact of plasma transaminase levels on the peripheral blood glutamate levels and memory functions in healthy subjects()
por: Kamada, Yoshihiro, et al.
Publicado: (2016)

Clozapine Treatment Is Associated With Higher Prescription Rate of Antipsychotic Monotherapy and Lower Prescription Rate of Other Concomitant Psychotropics: A Real-World Nationwide Study
por: Ochi, Shinichiro, et al.
Publicado: (2022)

Differences in self‐reported psychotic symptoms between patients with autism spectrum disorder and those with schizophrenia
por: Yamada, Momoka, et al.
Publicado: (2023)

Plasma Levels of Soluble Tumor Necrosis Factor Receptor 2 (sTNFR2) Are Associated with Hippocampal Volume and Cognitive Performance in Patients with Schizophrenia
por: Kudo, Noriko, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_9o5441gbsnt9rt7macnmgnp7ks